Genenta Science S.p.A. (GNTA) Financials

GNTA Assets vs Liabilities

DateAssetsLiabilities
June 30, 2023 29.1 million 2.1 million
March 31, 2023 36.4 million 2.5 million
Dec. 31, 2022 35.9 million 2.5 million
Sept. 30, 2022 32795 2254

GNTA Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2023 -8.2 million 226
March 31, 2023 -2657 262
Dec. 31, 2022 ? ?
Sept. 30, 2022 -2391 236

GNTA Net Income

No data available :(

GNTA Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2023 24.2 million - -
March 31, 2023 32.5 million - -
Dec. 31, 2022 32.0 million - -
Sept. 30, 2022 29222 - -

GNTA Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2023 19.8 million
March 31, 2023 19.9 million
Dec. 31, 2022 19.5 million
Sept. 30, 2022 17.9 million

GNTA Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2023 13397 4.2 million 1564 3.1 million
March 31, 2023 13 2015 1738 -
Dec. 31, 2022 13015 - - -
Sept. 30, 2022 11 1813 1564 -

GNTA Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2023 - 22775
March 31, 2023 - -
Dec. 31, 2022 - -
Sept. 30, 2022 - -

GNTA

Price: $2.04

52 week price:
0.55
10.00

Earnings Per Share: -0.55 USD

P/E Ratio: -1.67

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Italy

Volume: 5118

Market Capitalization: 40.4 million

Links: